You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
osimertinib price
Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.
The most common side effects include diarrhea, rash, musculoskeletal pain, dry skin, skin inflammation around nails, sore mouth, fatigue and cough.Osimertinib was approved for medical use in the United States in November 2015, and in the European Union in February 2016.